Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Sulbactam sodium compound and medical composition of sulbactam sodium compound and mezlocillin sodium

A technology of mezlocillin sodium and sulbactam sodium, which is applied in the field of medicine, can solve the problems of high impurity content, poor storage stability, and poor use safety, and achieve high safety performance, low impurity content, and good storage stability.

Active Publication Date: 2013-05-22
SHANXI C&Y PHARMACEUTICAL GROUP CO LTD
View PDF4 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The concentration of 2 μg / ml has strong inhibitory effect on Richmond-Syks Ⅱ, Ⅲ, Ⅳ and Ⅴ type β-lactamase, but has no effect on type I β-lactamase
[0007] The storage stability of sulbactam sodium in the prior art is relatively poor, and its related substances will increase significantly in light and humid environments, and its pharmaceutical composition with mezlocillin sodium is stored for a long time, and the impurity content is relatively high. Poor safety, in order to obtain a pharmaceutical composition of mezlocillin sodium and sulbactam sodium with better performance, the present invention is proposed

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Sulbactam sodium compound and medical composition of sulbactam sodium compound and mezlocillin sodium
  • Sulbactam sodium compound and medical composition of sulbactam sodium compound and mezlocillin sodium
  • Sulbactam sodium compound and medical composition of sulbactam sodium compound and mezlocillin sodium

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] Preparation of sulbactam sodium compound

[0037] N,N-dimethylformamide and water are formulated into a mixed solvent at a volume ratio of 3:1, and the raw material drug of sulbactam sodium is taken, and the mixed solvent of N,N-dimethylformamide and water is added, and the The ratio of the volume of the mixed solvent to the mass of sulbactam sodium is 5ml:1g, heat up to 70°C, stir until completely dissolved, keep warm, adjust the pH of the solution to 5.5, and flow the solution through 0.5T at a speed of 5m / s DC magnetic field, the direction of the magnetic field is perpendicular to the flow direction of the solution, add activated carbon to the solution after magnetic treatment for decolorization, the amount of activated carbon is 0.3% (g / ml) of the volume of the mixed solvent, stir for 30min, filter to obtain a clear solution, and pour it into the clear solution Add ethanol to the solution, the volume ratio of the ethanol to the mixed solvent is 5:1, filter to obtain...

Embodiment 2

[0040] Preparation of sulbactam sodium compound

[0041]N,N-dimethylformamide and water are prepared into a mixed solvent at a volume ratio of 1:1, and the raw material drug of sulbactam sodium is taken, and the mixed solvent of N,N-dimethylformamide and water is added, and the The ratio of the volume of the mixed solvent to the mass of sulbactam sodium is 3ml:1g, heat up to 60°C, stir until completely dissolved, keep warm, adjust the pH of the solution to 5.0, and flow the solution through 0.5T at a speed of 10m / s DC magnetic field, the direction of the magnetic field is perpendicular to the flow direction of the solution, add activated carbon to the solution after magnetic treatment for decolorization, the amount of activated carbon is 0.3% (g / ml) of the volume of the mixed solvent, stir for 30min, filter to obtain a clear solution, and pour it into the clear solution Add ethanol to the solution, the volume ratio of the ethanol to the mixed solvent is 10:1, filter to obtain ...

Embodiment 3

[0044] Preparation of Mezlocillin Sodium and Sulbactam Sodium Powder Injection

[0045] Take by weighing mezlocillin sodium and the sulbactam sodium that embodiment 1 prepares under aseptic condition, wherein the mass ratio of mezlocillin sodium and sulbactam sodium is 4:1, is placed in the solid powder mixer and evenly mixed, The raw materials obtained are transferred to the aseptic preparation workshop, where they are precisely measured and packaged. Each bottle contains 0.5 g of sulbactam sodium, which is stoppered and capped. The finished product is packaged and put into storage for inspection.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of medicines, and in particular relates to a sulbactam sodium compound and a medical composition of the sulbactam sodium compound and mezlocillin sodium. The sulbactam sodium compound is shown as by an X-ray powder diffraction spectrogram I measured by a Cu-K alpha ray. The sulbactam sodium compound provided by the invention has better storage stability. The invention further provides a preparation method of the sulbactam sodium compound as well as a medical composition of the sulbactam sodium compound and mezlocillin sodium. The medical composition has better storage stability and higher using safety performance.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a sulbactam sodium compound and a pharmaceutical composition thereof with mezlocillin sodium. Background technique [0002] Sulbactam sodium Chinese alias: (2S,5R)-3,3-Dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate sodium- 4,4-Dioxide; (2S-CIS)-3,3-Dimethyl-7-oxo-4-thio-1-azabicyclo[3,2,0]heptane-2-carboxy Acid 4,4-dioxide sodium salt; English name Sulbactam Sodium; Molecular formula: C 8 h 10 NNaO 5 S; Molecular weight: 255.22; Molecular structural formula is shown in the figure below: [0003] [0004] Sulbactam sodium is an irreversible competitive β-lactamase inhibitor, which can inhibit the β-lactamase produced by Gram-positive and negative bacteria (except Pseudomonas aeruginosa), and has an irreversible reaction with the enzyme After the enzyme is inactivated, the activity of the enzyme cannot be restored after the inhibitor is removed....

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D499/86C07D499/18A61K31/431A61K31/43A61P31/04
Inventor 闫晓晔
Owner SHANXI C&Y PHARMACEUTICAL GROUP CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com